Company
Kallyope
At Kallyope, we are leveraging unique insights into neural signaling pathways and developing innovative medicines for the treatment of migraine.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- New York City, New York, United States
- kallyope.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Kallyope was founded by world-leading neuroscientists whose groundbreaking research into previously unexplored neural networks is now being carried forward by a team of experienced drug developers.
Products
- Other
- Elismetrep
Loading relationship preview